AdvanCell Pty Limited
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study). (NCT05720130) | AdvanCell Pty Limited | 2023-03-15 |
Track AdvanCell Pty Limited automatically
Every clearance here is in the API, with alerts when new ones post.